Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: Effect of tranexamic acid (AMCA)
- 1 March 1981
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Acta Neurochirurgica
- Vol. 56 (1-2), 25-38
- https://doi.org/10.1007/bf01400969
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- A new method for the direct counting of the so-called blood platelets in man.Acta Medica Scandinavica, 2009
- THE USE OF ANTIFIBRINOLYTIC DRUGS TO PREVENT EARLY RECURRENT ANEURYSMAL SUBARACHNOID HAEMORRHAGEActa Neurologica Scandinavica, 2009
- FIBRINOLYTIC ACTIVITY OF THE CEREBROSPINAL FLUID AFTER SUBARACHNOID HAEMORRHAGEActa Neurologica Scandinavica, 2009
- Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?BMJ, 1978
- Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke.Stroke, 1976
- Fibrin/fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unitJournal of Neurology, Neurosurgery & Psychiatry, 1974
- 40. THE BIOLOGICAL AND PHARMACOLOGICAL PROPERTIES OF SOME FIBRINOGEN DEGRADATION PRODUCTS*Scandinavian Journal of Haematology, 1971
- Coagulation Abnormalities in Subarachnoid HemorrhageStroke, 1970
- Fibrinolysis in subarachnoid haemorrhagePublished by Oxford University Press (OUP) ,1967
- On an Inherited Autosomal Hemorrhagic Diathesis with Antihemophilic Globulin (AHG) Deficiency and Prolonged Bleeding Times1Acta Medica Scandinavica, 1957